The efficacy and safety of concurrent chemoradiotherapy for squamous cell carcinoma of the vulva. Phase II Study
Phase 2
Recruiting
- Conditions
- Vulva cancer
- Registration Number
- JPRN-UMIN000013439
- Lead Sponsor
- TGCU(Tohoku Gynecological Cancer Unit)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of chemotherapy or radiotherapy 2. Active double cancer 3. Active infection 4. Severe complicating illness ( bronchial asthma, pneumonia, ischemic heart disease, diabetes mellitus, arrhythmia) 5. Massive ascites or pleural fluid 6. History of severe allergic reaction 7. pregnant, lactating women and women who expects pregnant 8. Difficult case to keep the regulations and observations 9. Other reason that primary doctor think ineligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal control rate
- Secondary Outcome Measures
Name Time Method Progression free survival, Overall survival rate